Agilent Technologies, Inc. $A Shares Bought by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund increased its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 440.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,573 shares of the medical research company's stock after acquiring an additional 49,366 shares during the period. Healthcare of Ontario Pension Plan Trust Fund's holdings in Agilent Technologies were worth $6,904,000 at the end of the most recent reporting period.

Get Agilent Technologies SMS alerts:

Sign Up

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company's stock worth $82,712,000 after acquiring an additional 24,687 shares in the last quarter. CCLA Investment Management grew its stake in shares of Agilent Technologies by 1.9% in the 4th quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company's stock worth $142,542,000 after purchasing an additional 19,518 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company's stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Agilent Technologies by 20.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company's stock worth $7,269,000 after purchasing an additional 9,236 shares in the last quarter. Finally, Oak Thistle LLC acquired a new stake in Agilent Technologies during the fourth quarter valued at approximately $3,457,000.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. Wolfe Research restated a "hold" rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. TD Cowen raised their price objective on Agilent Technologies from $147.00 to $155.00 and gave the stock a "buy" rating in a research note on Thursday, May 28th. Wells Fargo & Company cut their target price on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a research report on Thursday, May 28th. Wall Street Zen downgraded Agilent Technologies from a "buy" rating to a "hold" rating in a report on Saturday, July 25th. Finally, Piper Sandler began coverage on Agilent Technologies in a research report on Thursday, June 11th. They issued a "neutral" rating and a $150.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, Agilent Technologies presently has an average rating of "Moderate Buy" and a consensus target price of $159.35.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $140.31 on Thursday. The company's fifty day moving average is $131.41 and its two-hundred day moving average is $125.27. The company has a market cap of $39.63 billion, a P/E ratio of 28.17, a price-to-earnings-growth ratio of 2.49 and a beta of 1.25. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.80 billion. During the same quarter last year, the firm posted $1.31 earnings per share. Agilent Technologies's revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 6.01 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were given a dividend of $0.255 per share. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies's dividend payout ratio (DPR) is presently 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.